INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
53 hedge funds and large institutions have $3.1M invested in Infinity Pharmaceuticals, Inc. in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-15
Holders Change %
-22.06%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
10
Reduced
13
Closed
18
Calls
$22K
Puts
$8K
Net Calls
+$14K
Net Calls Change
-$112K
Top Buyers
| 1 |
CC
Carlson Capital
Dallas,
Texas
|
+$160K |
| 2 |
E
Ergoteles
New York
|
+$100K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$62.9K |
| 4 |
WIM
Wittenberg Investment Management
Carlisle,
Massachusetts
|
+$27.5K |
| 5 |
VF
Virtu Financial
New York
|
+$17.4K |
